Jan 2012

Home >> Clinical Trials News Archive >> 2012 >> Jan 2012
2012 will be a decision point for many Israeli biomed companies (Hebrew).
 
The High Tech Industry Association (HTIA) and Israel Life Science Industry (ILSI) Organization have merged. The Israel Advanced Technology Industries (IATI) to act as the umbrella organization for High Tech, Life Science and Venture Capital Industries. Advocate Karin Mayer Rubinstein named CEO of IATI.
 
BioInvest Israel March 5-6 in Haifa. Nobel laureate Prof. Daniel Shechtman headlines the speaker list at the first biomed investment conference.

The Israeli Ministry of Health Clinical Trials Department will hold training days about clinical trials regulatory requirements in Medical Devices & Advanced Therapies (Hebrew)